A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma
Titel:
A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma
Auteur:
Bashir, Qaiser Khan, Hassan Thall, Peter F. Liu, Ping Shah, Nina Kebriaei, Partow Parmar, Simrit Oran, Betul Ciurea, Stefan Nieto, Yago Jones, Roy Hosing, Chitra M. Popat, Uday R. Dinh, Yvonne T. Rondon, Gabriela Orlowski, Robert Z. Shah, Jatin J. De Lima, Marcos Shpall, Elizabeth Champlin, Richard Giralt, Sergio Qazilbash, Muzaffar H.
Verschenen in:
Biology of blood and marrow transplantation
Paginering:
Jaargang 19 (2013) nr. 10 pagina's 6 p.
Jaar:
2013
Inhoud:
Uitgever:
American Society for Blood and Marrow Transplantation